Author
D. K. Gifford
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2023 · peak 4/yrCo-Author Collaboration Network
10 top collaborators · 27 mutual co-author links10 papers
Recent·Most cited
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
B. Carter, P. Huang, G. Liu, Y. Liang, P. J. C. Lin, B.-H. Peng, L. McKay, A. Dimitrakakis, J. Hsu, V. Tat, P. Saenkham-Huntsinger, J. Chen, C. Kaseke, G. D. Gaiha, Q. Xu, , D. K. Gifford
A T cell vaccine based on conserved epitopes protects HLA transgenic mice from SARS-CoV-2 Beta variant mortality without inducing neutralizing antibodies.
bioRxiv · Sep 23, 2022Immunology
A high-throughput yeast display approach to profile pathogen proteomes for MHC-II binding
B. D. Huisman, Z. Dai, D. K. Gifford, M. E. Birnbaum
The paper presents a high-throughput yeast display method to assess MHC-II binding of peptides from SARS-CoV-2 and dengue virus, identifying binders missed by computational predictions.
bioRxiv · Feb 22, 2022Immunology
Ultra high diversity factorizable libraries for efficient therapeutic discovery
Z. Dai, S. D. Saksena, G. Horny, C. Banholzer, S. Ewert, D. K. Gifford
The paper designs factorizable libraries for therapeutic discovery using an optimization method called SAPS to generate diverse and efficient antibody CDR-H3 sequences.
bioRxiv · Jan 17, 2022 · PreprintBioengineering
Preliminary Immunogenicity of a Pan-COVID-19 T Cell Vaccine in HLA-A*02:01 Mice
B. Carter, J. Chen, C. Kaseke, A. Dimitrakakis, G. D. Gaiha, Q. Xu, D. K. Gifford
This study tests a T cell vaccine in HLA-A*02:01 mice to assess its immunogenicity against SARS-CoV-2 variants.
bioRxiv · May 2, 2021 · PreprintImmunology
Extracting and Interpreting the Effects of Higher Order Sequence Features on Peptide MHC Binding
Z. Dai, B. D. Huisman, M. E. Birnbaum, D. K. Gifford
This paper extracts and interprets sequence features affecting peptide MHC binding using yeast display data, showing they accurately predict binding and align with structural knowledge.
bioRxiv · Nov 20, 2020 · PreprintImmunology
Machine learning optimization of peptides for presentation by class II MHCs
Z. Dai, B. D. Huisman, H. Zeng, B. Carter, S. Jain, M. E. Birnbaum, D. K. Gifford
The paper develops a machine learning method to optimize peptide binding to class II MHCs by modifying anchor residues, validated through a yeast display assay.
bioRxiv · Aug 18, 2020Immunology
Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and their Augmentation by Compact Peptide Sets
G. Liu, B. Carter, D. K. Gifford
The paper identifies gaps in SARS-CoV-2 subunit vaccine coverage for cellular immunity and proposes adding peptides to improve population coverage.
bioRxiv · Aug 4, 2020Immunology
Robust computational design and evaluation of peptide vaccines for cellular immunity with application to SARS-CoV-2
G. Liu, B. Carter, T. Bricken, S. Jain, M. Viard, M. Carrington, D. K. Gifford
The paper develops a machine learning method to design peptide vaccines for SARS-CoV-2, achieving high predicted coverage and robustness against epitope drift.
bioRxiv · May 16, 2020Immunology
Antibody Complementarity Determining Region Design Using High-Capacity Machine Learning
G. Liu, H. Zeng, J. Mueller, B. Carter, Z. Wang, J. Schilz, G. Horny, M. E. Birnbaum, S. Ewert, D. K. Gifford
This paper introduces a machine learning method to design human IgG antibodies with superior target affinity and specificity, using high-throughput data without requiring target structural information.
bioRxiv · Sep 3, 2019Immunology